派博傳思國(guó)際中心

標(biāo)題: Titlebook: Immunotoxicity Testing; Methods and Protocol Jamie C. DeWitt,Cheryl E. Rockwell,Christal C. Bow Book 2018Latest edition Springer Science+Bu [打印本頁(yè)]

作者: 搭話    時(shí)間: 2025-3-21 18:14
書(shū)目名稱Immunotoxicity Testing影響因子(影響力)




書(shū)目名稱Immunotoxicity Testing影響因子(影響力)學(xué)科排名




書(shū)目名稱Immunotoxicity Testing網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Immunotoxicity Testing網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Immunotoxicity Testing被引頻次




書(shū)目名稱Immunotoxicity Testing被引頻次學(xué)科排名




書(shū)目名稱Immunotoxicity Testing年度引用




書(shū)目名稱Immunotoxicity Testing年度引用學(xué)科排名




書(shū)目名稱Immunotoxicity Testing讀者反饋




書(shū)目名稱Immunotoxicity Testing讀者反饋學(xué)科排名





作者: KEGEL    時(shí)間: 2025-3-21 23:34
Clinical Immunotoxicologyf useful endpoints. It is therefore common to use a weight of evidence approach with nonclinical studies to indicate if there is a cause for concern that the test article has immunotoxic potential. The most commonly used follow-up assay for immunosuppression is the T-dependent antibody response (TDA
作者: Commonwealth    時(shí)間: 2025-3-22 01:24
Investigative Immunotoxicologymical or biologic agents that alter the immune system and affect human health. Immunotoxicology can manifest in a variety of ways, with one of the most prominent effects being immunosuppression. Immunosuppression can be defined as a reduced ability of the immune system to respond to a challenge from
作者: exorbitant    時(shí)間: 2025-3-22 06:51

作者: OTTER    時(shí)間: 2025-3-22 11:03

作者: 職業(yè)    時(shí)間: 2025-3-22 14:37
The Sheep Erythrocyte T-Dependent Antibody Response (TDAR)eep erythrocytes (sRBC). The assay enumerates the number of antigen-specific IgM antibody-producing cells in the spleen. When exposure to the test material takes place in vivo, as does sensitization, the actual quantification of the number of antibody-producing cells occurs ex vivo. Following the an
作者: 撤退    時(shí)間: 2025-3-22 20:50
Methylated Bovine Serum Albumin (mBSA)-Induced Delayed-Type Hypersensitivity in Mice antigen. Interestingly both Th1, the classical, and Th17, the more recently discovered, proinflammatory lineages have been implicated in disease progression. The duality of DTH makes it an ideal model system for understanding T-cell differentiation, memory cell formation, and the direct effect of t
作者: 變態(tài)    時(shí)間: 2025-3-23 00:03
Use of the LLNA:BrdU-ELISA for Skin Sensitization Hazard Assessmentests to reduce the incidence of skin sensitization leading to clinical manifestations of ACD. For more than a decade, the murine local lymph node assay (LLNA) has been the method of choice for the identification of skin sensitizers. While the original LLNA protocol has been extensively evaluated and
作者: dainty    時(shí)間: 2025-3-23 05:08

作者: 后來(lái)    時(shí)間: 2025-3-23 08:54
Enhanced Histopathology Evaluation of Lymphoid Organs the assumption that chemically induced alterations may result in qualitative or quantitative changes in the histology of the lymphoid organs. It involves the histological evaluation of various lymphoid organs and their respective tissue compartments to identify specific cellular and architectural c
作者: JAMB    時(shí)間: 2025-3-23 12:42

作者: Forsake    時(shí)間: 2025-3-23 17:24

作者: 收藏品    時(shí)間: 2025-3-23 19:03
Evaluation of Cell-Mediated Immune Function Using the Cytotoxic T-Lymphocyte Assaysk underlying health risks. Among measures of CMI, the cytotoxic T-lymphocyte (CTL) response is recognized as perhaps the most relevant functional measure that reflects cell-mediated acquired immune defense against viral infections and cancer. The CTL response against T-dependent antigens requires t
作者: aggressor    時(shí)間: 2025-3-24 00:42
Evaluation of Cell Proliferation and Apoptosis in Immunotoxicity Testingf numerous toxicants, and the adverse effects include serious health complications such as susceptibility to infections, cancer, allergic reactions, and autoimmune diseases. One way to investigate the harmful effects of different chemicals is to study apoptosis and/or proliferation in immune cells.
作者: 合唱團(tuán)    時(shí)間: 2025-3-24 05:23

作者: 圣人    時(shí)間: 2025-3-24 07:00
igned for clarity and ease of use.Includes supplementary mat.Clinical Care Pathways in Andrology .provides a valuable resource for understanding clinical decision-making in the context of the predominant male reproductive and sexual disorders for which patients commonly seek evaluation and treatment
作者: Nonflammable    時(shí)間: 2025-3-24 12:06

作者: 向外才掩飾    時(shí)間: 2025-3-24 18:37

作者: Mri485    時(shí)間: 2025-3-24 23:05
L. Peyton Myersigned for clarity and ease of use.Includes supplementary mat.Clinical Care Pathways in Andrology .provides a valuable resource for understanding clinical decision-making in the context of the predominant male reproductive and sexual disorders for which patients commonly seek evaluation and treatment
作者: MIR    時(shí)間: 2025-3-25 02:36

作者: intention    時(shí)間: 2025-3-25 07:19

作者: miracle    時(shí)間: 2025-3-25 11:20

作者: miniature    時(shí)間: 2025-3-25 15:06

作者: adumbrate    時(shí)間: 2025-3-25 19:11

作者: 空中    時(shí)間: 2025-3-25 20:18
Jessica Margaret Sidoigned for clarity and ease of use.Includes supplementary mat.Clinical Care Pathways in Andrology .provides a valuable resource for understanding clinical decision-making in the context of the predominant male reproductive and sexual disorders for which patients commonly seek evaluation and treatment
作者: 偽善    時(shí)間: 2025-3-26 04:08

作者: 業(yè)余愛(ài)好者    時(shí)間: 2025-3-26 07:29

作者: 情節(jié)劇    時(shí)間: 2025-3-26 12:19
Susan A. Elmoreigned for clarity and ease of use.Includes supplementary mat.Clinical Care Pathways in Andrology .provides a valuable resource for understanding clinical decision-making in the context of the predominant male reproductive and sexual disorders for which patients commonly seek evaluation and treatment
作者: 支形吊燈    時(shí)間: 2025-3-26 16:33
Sheung P. Ng,Judith T. Zelikoffigned for clarity and ease of use.Includes supplementary mat.Clinical Care Pathways in Andrology .provides a valuable resource for understanding clinical decision-making in the context of the predominant male reproductive and sexual disorders for which patients commonly seek evaluation and treatment
作者: 確定方向    時(shí)間: 2025-3-26 17:36
igned for clarity and ease of use.Includes supplementary mat.Clinical Care Pathways in Andrology .provides a valuable resource for understanding clinical decision-making in the context of the predominant male reproductive and sexual disorders for which patients commonly seek evaluation and treatment
作者: CORE    時(shí)間: 2025-3-26 21:46

作者: Incorporate    時(shí)間: 2025-3-27 04:54

作者: 光亮    時(shí)間: 2025-3-27 08:50

作者: 假設(shè)    時(shí)間: 2025-3-27 09:34

作者: arrogant    時(shí)間: 2025-3-27 14:23

作者: 越自我    時(shí)間: 2025-3-27 21:40

作者: maudtin    時(shí)間: 2025-3-28 01:49
Book 2018Latest editionures and the background information needed to identify effective testing approaches. Dedicated to identifying and describing exogenous agents that can modify immune function, uncovering modes and mechanisms of action for such agents, and translating data from the laboratory and from the clinic to be
作者: ENACT    時(shí)間: 2025-3-28 03:20
Use of the LLNA:BrdU-ELISA for Skin Sensitization Hazard Assessment analog of 3HTdR. The LLNA:BrdU-ELISA has been reviewed, validated, and approved for use internationally, and its performance is regarded as equivalent to the traditional LLNA. Here, we provide guidance on how to perform and interpret data from this assay.
作者: 祖?zhèn)?nbsp;   時(shí)間: 2025-3-28 08:24

作者: 兵團(tuán)    時(shí)間: 2025-3-28 13:48

作者: 廣大    時(shí)間: 2025-3-28 15:08
Immunotoxicology: A Brief Historyd the field of immunotoxicology, which addresses all aspects of adverse immunological responses following exposure to exogenous agents as well as the development of testing paradigms to understand immunological responses of designed agents such as drugs and biologics.
作者: Pander    時(shí)間: 2025-3-28 18:59

作者: nauseate    時(shí)間: 2025-3-28 23:56

作者: Noctambulant    時(shí)間: 2025-3-29 04:42

作者: Aprope    時(shí)間: 2025-3-29 11:03
Flow Cytometry for the Immunotoxicologistid) as well as in novel models recently being utilized in the field of toxicology. These methods can be used for current testing and to determine mechanisms by which a xenobiotic can cause immunotoxicity.
作者: largesse    時(shí)間: 2025-3-29 11:37

作者: gerontocracy    時(shí)間: 2025-3-29 16:14
Methods in Molecular Biologyhttp://image.papertrans.cn/i/image/462315.jpg
作者: arterioles    時(shí)間: 2025-3-29 20:00

作者: 無(wú)孔    時(shí)間: 2025-3-30 00:08
978-1-4939-9322-2Springer Science+Business Media, LLC, part of Springer Nature 2018
作者: CHYME    時(shí)間: 2025-3-30 07:42
Immunotoxicity Testing978-1-4939-8549-4Series ISSN 1064-3745 Series E-ISSN 1940-6029
作者: 神化怪物    時(shí)間: 2025-3-30 09:22
Dendritic Cell AssaysGeneration of dendritic cells from both mouse and human tissues is a valuable technique for downstream immunotoxicological applications. Here, we describe methods for generation of four subsets of dendritic cells from murine bone marrow and three subsets of dendritic cells from human peripheral blood mononuclear cells.
作者: 竊喜    時(shí)間: 2025-3-30 14:38

作者: farewell    時(shí)間: 2025-3-30 19:07

作者: 我邪惡    時(shí)間: 2025-3-30 22:34
step in diagnosis and management.? .?.Designed for clarity and ease of use, .Clinical Care Pathways in Andrology. is a practical and valuable reference for urologists, primary care physicians, and residents who are not specialty trained in andrology..978-1-4939-4288-6978-1-4614-6693-2
作者: Permanent    時(shí)間: 2025-3-31 01:44

作者: 笨拙處理    時(shí)間: 2025-3-31 05:41

作者: 精致    時(shí)間: 2025-3-31 10:15

作者: AXIS    時(shí)間: 2025-3-31 13:47

作者: Paleontology    時(shí)間: 2025-3-31 19:37





歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
甘孜县| 大庆市| 三亚市| 汉寿县| 海晏县| 武功县| 温宿县| 陇西县| 荆州市| 济阳县| 疏附县| 黑水县| 自治县| 兴国县| 额敏县| 乐都县| 马边| 怀远县| 石柱| 吉木乃县| 大英县| 吉安县| 泰顺县| 邛崃市| 浙江省| 石城县| 平乡县| 徐州市| 澄江县| 毕节市| 晋江市| 邹平县| 德钦县| 明光市| 堆龙德庆县| 前郭尔| 三门县| 揭西县| 东源县| 潼南县| 曲麻莱县|